Change search
ReferencesLink to record
Permanent link

Direct link
Human seroreactivity to gut microbiota antigens
University of Alabama Birmingham, AL 35294 USA.
Linköping University, Department of Clinical and Experimental Medicine, Division of Clinical Sciences. Region Östergötland, Center of Paediatrics and Gynaecology and Obstetrics, Department of Paediatrics in Linköping. Linköping University, Faculty of Medicine and Health Sciences.
University of Manitoba, Canada.
University of Alabama Birmingham, AL 35294 USA.
Show others and affiliations
2015 (English)In: Journal of Allergy and Clinical Immunology, ISSN 0091-6749, E-ISSN 1097-6825, Vol. 136, no 5, 1378-1386 p.Article in journal (Refereed) Published
Abstract [en]

Background: Although immune responses directed against antigens from the intestinal microbiota are observed in certain diseases, the normal human adaptive immune response to intestinal microbiota is poorly defined. Objective: Our goal was to assess the adaptive immune response to the intestinal microbiota present in 143 healthy adults and compare this response with the response observed in 52 children and their mothers at risk of having allergic disease. Methods: Human serum was collected from adults and children followed from birth to 7 years of age, and the serum IgG response to a panel of intestinal microbiota antigens was assessed by using a novel protein microarray. Results: Nearly every subject tested, regardless of health status, had serum IgG that recognized a common set of antigens. Seroreactivity to the panel of antigens was significantly lower in atopic adults. Healthy infants expressed the highest level of IgG seroreactivity to intestinal microbiota antigens. This adaptive response developed between 6 and 12 months of age and peaked around 2 years of age. Low IgG responses to certain clusters of microbiota antigens during infancy were associated with allergy development during childhood. Conclusions: There is an observed perturbation of the adaptive response to antigens from the microbiota in allergic subjects. These perturbations are observable even in childhood, suggesting that optimal stimulation of the adaptive immune system by the microbiota might be needed to prevent certain immune-mediated diseases.

Place, publisher, year, edition, pages
MOSBY-ELSEVIER , 2015. Vol. 136, no 5, 1378-1386 p.
Keyword [en]
Adaptive; atopy; allergy; childhood; IgG; microarray; microbiota; bacterial antigens; bacterial antibodies
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-123148DOI: 10.1016/j.jaci.2015.03.036ISI: 000364787200028PubMedID: 26014812OAI: diva2:877628

Funding Agencies|National Institutes of Health [DK071176]; Swedish Research Council [K2011-56X-21854-01-06]; Swedish Heart-Lung Foundation [20050514]; Ekhaga Foundation [210-53]; Research Council for the South-East Sweden; Olle Engqvist Foundation; Swedish Asthma and Allergy Association; Vardal Foundation for Health Care Science and Allergy Research, Sweden [B2007 042]; University Hospital of Linkoping, Sweden

Available from: 2015-12-07 Created: 2015-12-04 Last updated: 2016-01-20

Open Access in DiVA

fulltext(618 kB)4 downloads
File information
File name FULLTEXT01.pdfFile size 618 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Abrahamsson, ThomasBerg, GöranJenmalm, Maria
By organisation
Division of Clinical SciencesDepartment of Paediatrics in LinköpingFaculty of Medicine and Health SciencesDepartment of Gynaecology and Obstetrics in LinköpingDivision of Neuro and Inflammation Science
In the same journal
Journal of Allergy and Clinical Immunology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 4 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 92 hits
ReferencesLink to record
Permanent link

Direct link